{"id":"tp-54330","type":"article-newspaper","title":"Novartis Presents Two-Year Ianalumab Results in Sjögren’s Disease","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54330","datePublished":"2026-11-11T18:48:45.000Z","dateModified":"2026-11-11T18:48:45.000Z","language":"en","abstract":"Results from the NEPTUNUS extension study showed further improvements in disease activity.","section":"Business","references":[]}